2024 ACS NRTCC National Meeting - Public Session

Westchester Medical Center and New York Medical College

I am a board certified gynecologic oncologist at Westchester Medical Center and New York Medical College, where I serve as the Associate Chair for Quality and Safety and the Director of Quality and Safety for the Department of Obstetrics and Gynecology. My work has focused on the prevention and treatment of cervical cancer and I serve as the head of quality assurance for the NIH international moonshot focusing on developing new technologies to screen for cervical cancer. I am passionate about improving the care of underserved populations through the development of new technologies that will reduce the burden to the patients and improve access to screening.

American Cancer Society, Director, ACS NRTCC

Shelly serves as Director of the American Cancer Society National Roundtable on Cervical Cancer. A champion of health equity, Shelly is an outspoken cervical cancer survivor with over 30 years of volunteer and civic engagement history. Her ambitions include advancing systems, policy, and environmental changes to address the social determinates of health and eliminating cervical cancer as a public health problem in her lifetime. A graduate of West Virginia University, Shelly worked nearly a decade at WVU Cancer Institute’s Cancer Prevention and Control, where she was recognized for her HPV vaccination advocacy and for her work engineering and instituting policy, systems, and environmental changes through the WV Breast and Cervical Cancer Screening Program. During this time she also served as a Workgroup leader, Chair and Chair Emeritus of Mountains of Hope, the West Virginia’s Comprehensive Cancer Coalition. Shelly remains involved in the Quality of Life workgroup leading the work to champion legislation to decrease out of pocket costs for oral health services when related to a cancer diagnosis. In her role as Director of the ACS National Roundtable on Cervical Cancer, Shelly works with organizations from across the US to identify and address the problems that no one organization can solve on its own. Utilizing the strength of the ACS Roundtable Model the ACS NRTCC addresses the six greatest challenges identified by stakeholders across the cervical cancer continuum. These priorities were recently featured as poster presentations at the 2023 International Papillomavirus Conference in Washington, DC, and can be viewed at https://cervicalroundtable.org/

Vice President, National Roundtables & Coalitions American Cancer Society

Sarah Shafir, MPH, is the Vice President, National Roundtables & Coalitions for the American Cancer Society leading its national convening strategy that engages multi-sectored public and private organizations, diverse communities, and people with lived experiences through collective action to overcome the most pressing challenges impeding our progress in improving cancer outcomes. Ms. Shafir provides overall strategy; execution; data collection, tracking, and evaluation; and resource allocation support to its 6 mission-critical national roundtables focused on colorectal cancer, lung cancer, HPV vaccination, breast cancer, cervical cancer, and patient navigation. She serves as the co-Principal Investigator of the organization’s technical assistance and training program for the 66 CDC-funded comprehensive cancer control programs and coalitions. Ms. Shafir has more than 30 years of experience in public health and coalition development and sustainability. She has worked at the local, state, national and international levels in both government and not-for-profit organizations. Ms. Shafir is highly skilled at developing effective outcomes-based strategies and managing strategic partnerships. Ms. Shafir has a Bachelor of Science from the University of Maine at Farmington and a Master of Public Health from Tulane University School of Public Health and Tropical Medicine.

Moffitt Cancer Center

Susan T. Vadaparampil, PhD, MPH Community Outreach, Engagement & Equity Associate Center Director Since 2018, Dr. Susan Vadaparampil has served as Moffitt’s first Associate Center Director for Community Outreach, Engagement & Equity (COEE). In this role, she oversees the Office of COEE daily functions in support of Moffitt’s commitment to maximize the Center’s impact in the catchment area and beyond. The Office of COEE places health equity at the forefront of Moffitt’s research and outreach efforts by facilitating ongoing and bidirectional exchange of information and ideas between institutional leadership, faculty and the community we serve. Dr. Vadaparampil is also a Senior Member in the Health Outcomes and Behavior Program in the Division of Population Sciences and a Professor in the Department of Oncologic Sciences at the University of South Florida College of Medicine. Her research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to improve dissemination and uptake of new cancer prevention and control innovations into clinical practice and the community. Her work is influenced by transdisciplinary collaboration, focused on health disparities, and contributes to both the scientific literature and clinical practice. Her current research focuses on genetic counseling and testing for inherited cancer susceptibility, breast and cervical cancer prevention/early detection, and reproductive health among adolescent and young adult cancer patients. She has been funded since 2006 through research grants from organizations such as the National Institutes of Health, the American Cancer Society and the Florida Biomedical Research Program. Dr. Vadaparampil has published over 280 scientific manuscripts. She also serves as the Co-Program Director for Moffitt’s Behavioral Oncology Post-Doctoral Training Program.

West Virginia University Cancer Institute

Dr. Hannah Hazard-Jenkins is the Executive Chair and Director of WVU Cancer Institute, leading since 2020 with a focus on expanding regional cancer centers and improving access to care across West Virginia and enhancing research for our rural population. As a board-certified general surgeon and professor at WVU School of Medicine, she has held various leadership positions, including division chief of Surgical Oncology. Recognized for her dedication, Dr. Hazard-Jenkins has received accolades like Clinician of the Year. She has authored over 45 publications and completed her medical training at West Virginia University and Northwestern University, specializing in breast diseases. Her work aims to eliminate disparities in cancer outcomes, reflecting her commitment to advancing oncology and medical education in her home state. Hannah Hazard-Jenkins, MD Executive Chair and Director, WVU Cancer Institute Jean and Laurence DeLynn Chair of Oncology.

Moffitt Cancer Center

Susan T. Vadaparampil, PhD, MPH Community Outreach, Engagement & Equity Associate Center Director Since 2018, Dr. Susan Vadaparampil has served as Moffitt’s first Associate Center Director for Community Outreach, Engagement & Equity (COEE). In this role, she oversees the Office of COEE daily functions in support of Moffitt’s commitment to maximize the Center’s impact in the catchment area and beyond. The Office of COEE places health equity at the forefront of Moffitt’s research and outreach efforts by facilitating ongoing and bidirectional exchange of information and ideas between institutional leadership, faculty and the community we serve. Dr. Vadaparampil is also a Senior Member in the Health Outcomes and Behavior Program in the Division of Population Sciences and a Professor in the Department of Oncologic Sciences at the University of South Florida College of Medicine. Her research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to improve dissemination and uptake of new cancer prevention and control innovations into clinical practice and the community. Her work is influenced by transdisciplinary collaboration, focused on health disparities, and contributes to both the scientific literature and clinical practice. Her current research focuses on genetic counseling and testing for inherited cancer susceptibility, breast and cervical cancer prevention/early detection, and reproductive health among adolescent and young adult cancer patients. She has been funded since 2006 through research grants from organizations such as the National Institutes of Health, the American Cancer Society and the Florida Biomedical Research Program. Dr. Vadaparampil has published over 280 scientific manuscripts. She also serves as the Co-Program Director for Moffitt’s Behavioral Oncology Post-Doctoral Training Program.

Mayo Clinic

Dr. MacLaughlin is an Associate Professor of Family Medicine at Mayo Clinic’s Family Medicine residency program. She co-chairs the HPV Self-Collection group for the ACS National Roundtable on Cervical Cancer and previously co-chaired the IT/EHR group for the ACS Primary HPV Screening Initiative. She is on a CDC clinician advisory board contributing to development of clinical decision support for abnormal cervical cancer screening results management. She has also served as a subject matter expert for NORC in their work with the Federal Cervical Cancer Collaborative on the Cervical Cancer Moonshot℠ Roundtable Series and with HRSA’s Office of Women’s Health Cervical Cancer ECHO Learning Series for Safety-Net Settings.

Boston University

Dr. Perkins is a Professor of Obstetrics and Gynecology at Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center. Her career is dedicated to reducing health disparities in cervical cancer. Her current research focuses on improving utilization of HPV vaccination and cervical cancer screening guidelines. She co-chaired the President’s Cancer Panel Cervical Cancer Subcommittee, and is currently Co-Chairing the Enduring Consensus Cervical Cancer Screening and Management Guidelines and serving as a steering committee member on the National Roundtable on Cervical Cancer. She is also working with the US National Cancer Institute on a multi-country project related to cervical cancer prevention in resource-limited settings.

Westchester Medical Center and New York Medical College

I am a board certified gynecologic oncologist at Westchester Medical Center and New York Medical College, where I serve as the Associate Chair for Quality and Safety and the Director of Quality and Safety for the Department of Obstetrics and Gynecology. My work has focused on the prevention and treatment of cervical cancer and I serve as the head of quality assurance for the NIH international moonshot focusing on developing new technologies to screen for cervical cancer. I am passionate about improving the care of underserved populations through the development of new technologies that will reduce the burden to the patients and improve access to screening.

American Cancer Society ACS NRTCC

Facilitator

American Cancer Society, Director, ACS NRTCC

Shelly serves as Director of the American Cancer Society National Roundtable on Cervical Cancer. A champion of health equity, Shelly is an outspoken cervical cancer survivor with over 30 years of volunteer and civic engagement history. Her ambitions include advancing systems, policy, and environmental changes to address the social determinates of health and eliminating cervical cancer as a public health problem in her lifetime. A graduate of West Virginia University, Shelly worked nearly a decade at WVU Cancer Institute’s Cancer Prevention and Control, where she was recognized for her HPV vaccination advocacy and for her work engineering and instituting policy, systems, and environmental changes through the WV Breast and Cervical Cancer Screening Program. During this time she also served as a Workgroup leader, Chair and Chair Emeritus of Mountains of Hope, the West Virginia’s Comprehensive Cancer Coalition. Shelly remains involved in the Quality of Life workgroup leading the work to champion legislation to decrease out of pocket costs for oral health services when related to a cancer diagnosis. In her role as Director of the ACS National Roundtable on Cervical Cancer, Shelly works with organizations from across the US to identify and address the problems that no one organization can solve on its own. Utilizing the strength of the ACS Roundtable Model the ACS NRTCC addresses the six greatest challenges identified by stakeholders across the cervical cancer continuum. These priorities were recently featured as poster presentations at the 2023 International Papillomavirus Conference in Washington, DC, and can be viewed at https://cervicalroundtable.org/

American Cancer Society HPVRT

Facilitator

American Cancer Society Program Manager, ACS NRTCC/ ACS HPVRT

Facilitator

American Cancer Society

Facilitator

American Cancer Society, Program Manager ACS NRTCC

Facilitator

American Cancer Society

Facilitator

American Cancer Society, National Roundtables and Patient Support

Facilitator

American Cancer Society

Facilitator

Westchester Medical Center and New York Medical College

I am a board certified gynecologic oncologist at Westchester Medical Center and New York Medical College, where I serve as the Associate Chair for Quality and Safety and the Director of Quality and Safety for the Department of Obstetrics and Gynecology. My work has focused on the prevention and treatment of cervical cancer and I serve as the head of quality assurance for the NIH international moonshot focusing on developing new technologies to screen for cervical cancer. I am passionate about improving the care of underserved populations through the development of new technologies that will reduce the burden to the patients and improve access to screening.

Moffitt Cancer Center

Susan T. Vadaparampil, PhD, MPH Community Outreach, Engagement & Equity Associate Center Director Since 2018, Dr. Susan Vadaparampil has served as Moffitt’s first Associate Center Director for Community Outreach, Engagement & Equity (COEE). In this role, she oversees the Office of COEE daily functions in support of Moffitt’s commitment to maximize the Center’s impact in the catchment area and beyond. The Office of COEE places health equity at the forefront of Moffitt’s research and outreach efforts by facilitating ongoing and bidirectional exchange of information and ideas between institutional leadership, faculty and the community we serve. Dr. Vadaparampil is also a Senior Member in the Health Outcomes and Behavior Program in the Division of Population Sciences and a Professor in the Department of Oncologic Sciences at the University of South Florida College of Medicine. Her research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to improve dissemination and uptake of new cancer prevention and control innovations into clinical practice and the community. Her work is influenced by transdisciplinary collaboration, focused on health disparities, and contributes to both the scientific literature and clinical practice. Her current research focuses on genetic counseling and testing for inherited cancer susceptibility, breast and cervical cancer prevention/early detection, and reproductive health among adolescent and young adult cancer patients. She has been funded since 2006 through research grants from organizations such as the National Institutes of Health, the American Cancer Society and the Florida Biomedical Research Program. Dr. Vadaparampil has published over 280 scientific manuscripts. She also serves as the Co-Program Director for Moffitt’s Behavioral Oncology Post-Doctoral Training Program.

Vice President, National Roundtables & Coalitions American Cancer Society

Sarah Shafir, MPH, is the Vice President, National Roundtables & Coalitions for the American Cancer Society leading its national convening strategy that engages multi-sectored public and private organizations, diverse communities, and people with lived experiences through collective action to overcome the most pressing challenges impeding our progress in improving cancer outcomes. Ms. Shafir provides overall strategy; execution; data collection, tracking, and evaluation; and resource allocation support to its 6 mission-critical national roundtables focused on colorectal cancer, lung cancer, HPV vaccination, breast cancer, cervical cancer, and patient navigation. She serves as the co-Principal Investigator of the organization’s technical assistance and training program for the 66 CDC-funded comprehensive cancer control programs and coalitions. Ms. Shafir has more than 30 years of experience in public health and coalition development and sustainability. She has worked at the local, state, national and international levels in both government and not-for-profit organizations. Ms. Shafir is highly skilled at developing effective outcomes-based strategies and managing strategic partnerships. Ms. Shafir has a Bachelor of Science from the University of Maine at Farmington and a Master of Public Health from Tulane University School of Public Health and Tropical Medicine.

American Cancer Society

Liora Sahar, PhD, is a Geodetic engineer and GIS Professional (GISP) with experience in research, industry, government consulting, non-profit, and military domains, specializing in data analytics, geospatial sciences, remote sensing, and algorithm and software development. A graduate of Georgia Institute of Technology (GA Tech), Liora served as adjunct faculty while leading the Geospatial Solutions Team at ACS, comprising professionals with backgrounds and experiences in GIS, city planning, environmental sciences, and geography. This team actively participates in research projects and supports the daily activities of ACS programs, pillars, and regions. Sahar provides leadership, expertise, and operational support within ACS and to partners, focusing on the integration of Geographic Information Systems and Science within organizational projects and research.

American Cancer Society Program Manager, ACS NRTCC/ ACS HPVRT

Facilitator

American Cancer Society, Program Manager ACS NRTCC

Facilitator

University of New Mexico

Subject Matter Expert

University of New Mexico

Subject Matter Expert

O'Neal Comprehensive Cancer Center

Subject Matter Expert

Alabama Department of Public Health

Subject Matter Expert

Arthur G. James Cancer Hospital

Subject Matter Expert

National Institutes of Health

Subject Matter Expert

Northwestern University

Subject Matter Expert

St. Jude Children's Hospital

Subject Matter Expert

St. Jude Children's Hospital

Subject Matter Expert

ACS CAN

Subject Matter Expert

Adjunct Professor, Global Health Professor, Obstetrics and Gynecology

Subject Matter Expert

South Central Foundation

Subject Matter Expert

Teal Health

Subject Matter Expert

Boston University

Dr. Perkins is a Professor of Obstetrics and Gynecology at Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center. Her career is dedicated to reducing health disparities in cervical cancer. Her current research focuses on improving utilization of HPV vaccination and cervical cancer screening guidelines. She co-chaired the President’s Cancer Panel Cervical Cancer Subcommittee, and is currently Co-Chairing the Enduring Consensus Cervical Cancer Screening and Management Guidelines and serving as a steering committee member on the National Roundtable on Cervical Cancer. She is also working with the US National Cancer Institute on a multi-country project related to cervical cancer prevention in resource-limited settings.

American Cancer Society, Director, ACS NRTCC

Shelly serves as Director of the American Cancer Society National Roundtable on Cervical Cancer. A champion of health equity, Shelly is an outspoken cervical cancer survivor with over 30 years of volunteer and civic engagement history. Her ambitions include advancing systems, policy, and environmental changes to address the social determinates of health and eliminating cervical cancer as a public health problem in her lifetime. A graduate of West Virginia University, Shelly worked nearly a decade at WVU Cancer Institute’s Cancer Prevention and Control, where she was recognized for her HPV vaccination advocacy and for her work engineering and instituting policy, systems, and environmental changes through the WV Breast and Cervical Cancer Screening Program. During this time she also served as a Workgroup leader, Chair and Chair Emeritus of Mountains of Hope, the West Virginia’s Comprehensive Cancer Coalition. Shelly remains involved in the Quality of Life workgroup leading the work to champion legislation to decrease out of pocket costs for oral health services when related to a cancer diagnosis. In her role as Director of the ACS National Roundtable on Cervical Cancer, Shelly works with organizations from across the US to identify and address the problems that no one organization can solve on its own. Utilizing the strength of the ACS Roundtable Model the ACS NRTCC addresses the six greatest challenges identified by stakeholders across the cervical cancer continuum. These priorities were recently featured as poster presentations at the 2023 International Papillomavirus Conference in Washington, DC, and can be viewed at https://cervicalroundtable.org/

South Boston Community Medical Center

Subject Matter Expert

Professor and Chair- Department of Pathology University of New Mexico Health Sciences Center

<p></p><div style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 1em; margin-bottom: 1em; font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; color: #000000;"><a href="mailto:njoste@salud.unm.edu" target="_blank" style="color: #1155cc;" rel="noopener noreferrer"></a></div>

University of Utah

Deanna Kepka, PhD, MPH, is a Huntsman Cancer Institute (HCI) investigator and an assistant professor in the College of Nursing at the University of Utah. She is a member of the Cancer Control and Population Sciences (CCPS) research group Kepka’s main research interests are the gaps in health care access and quality for vulnerable populations. She focuses specifically on preventing cervical cancer among US Latinas, who have higher rates of cervical cancer than most other racial and ethnic groups. Utah has one of the lowest rates of completion of the HPV vaccination series in the country, and Kepka’s work with CCPS and the College of Nursing intends to develop more effective patient-provider interventions that will help increase this rate. She is also dedicated to improving health care services for cancer prevention and control among minority and underserved populations. Kepka has worked with teams in at-risk communities, promoting positive health behaviors in Jamaica, Chicago, North Carolina, and Washington. Since 2007, she has worked with Hispanic and Latino communities in Mexico, Peru, Chicago, North Carolina, and Washington. She has also developed a radionovela (a Spanish short story broadcast) that successfully improved knowledge and sparked interest in the HPV vaccine among rural Latino parents in the United States. Kepka was most recently a posdoctoral fellow in the Cancer Prevention Fellowship Program at the National Cancer Institute in Bethesda, Maryland, where she received the Cancer Prevention Fellowship Merit Award. She received her PhD in health services from the University of Washington School of Public Health and her MPH from the University of North Carolina at Chapel Hill Gillings School of Global Public Health.

Cervical Cancer Survivor, Lived Experience Expert, and Patient Advocate

Joslyn Chaiprasert-Paguio, a cervical cancer survivor, has transformed her journey into a powerful advocacy mission. Fueled by her own experience, she tirelessly educates others, promotes HPV vaccination, and advocates for regular cervical cancer screenings. She has delivered talks at UC San Diego Moores Cancer Center’s Cancer Control Annual Retreat, Foundation of Women’s Cancer Education Forum and Cervivor’s Cervical Cancer Summit, while also participating in panels dedicated to HPV vaccine awareness. Currently, Joslyn serves on the American Cancer Society National Round Table on Cervical Cancer Patient/Consumer Education Workgroup, contributing her expertise to shape patient education initiatives nationwide. Her story has reached diverse audiences through platforms like NBC Palm Springs, Kaiser Health News, and EverydayHealth, amplifying awareness and understanding of cervical cancer. As the host of the Cervivor podcast, Joslyn creates a platform for cervical cancer patients and survivors to share their journeys, providing invaluable support and insight. Through this podcast, she fosters a sense of community, addresses crucial topics, and empowers those affected by cervical cancer. Beyond her advocacy work, Joslyn finds joy in simple pleasures, indulging in reading, cooking, and exploring the world with her family. Her resilience, passion, and dedication continue to inspire positive change in the fight against cervical cancer.

Cervical Cancer Survivor, Lived Experience Expert , and Patient Advocate

My cervical cancer journey started 17 years ago. From the time my symptoms started, until my radical hysterectomy, was 3 months. My tumor was 90% of my cervix. I have volunteered with ACS for 14 years. I started participating in the Relay for Life as a team captain. I joined the committee for my local Relay for life 1 year later and was on the committee for 3 years. I have had my story shared in local newspapers, social media sites for ACS of Minnesota. In Minnesota, I participated in planning and putting on an event called “Turn it Teal Day” in Jan of 2023. With a lot of help from ACS, we had 12 buildings in the Twin Cities area, light up teal. We were able to get the Governor of Minnesota, and my local Mayor, provide us with a Government proclamation declaring Jan 19, 2023 Cervical Cancer Awareness Day. I recently relocated to Texas. I am working with an amazing team with ACS in Austin, Texas to spread awareness of cervical cancer as well as promoting ACS and what they do. The work that I do with ACS, is very important and special to me. I advocate for the HPV vaccine and for awareness of cervical cancer. I feel that everyone needs to know about HPV and how it relates to cervical cancer. In my free time, I enjoy acrylic painting, spending time with my boyfriend and our 3 dogs. We recently adopted our second special needs animal. I am expecting my first grandchild in February and I am very excited!

Cervical Cancer Survivor, Lived Experience Expert , and Patient Advocate

Tiera Wade is an artist turned advocate who has transformed her personal battle with stage 2b cervical cancer into a powerful platform for change. Diagnosed in June 2020, she refers to her cancer journey as the "best worst thing" that happened to her—a phrase that captured attention and became the headline of her feature in The Health Ability Project. Tiera's advocacy work is both extensive and impactful. She has shared her story and insights in Prevention Magazine, local cancer community centers, and as a valued participant on award-winning hospital patient panels, where she works to bridge the crucial gap between healthcare providers and patient care. Her dedication to promoting regular screenings and raising awareness is woven into the fabric of her personal business, where she emphasizes the importance of womb health through her handcrafted waist beads. “I seize every opportunity to encourage my clients to prioritize their health by scheduling screenings,” she affirms. Residing in Ohio with her husband and three daughters, Tiera is a passionate supporter of Cervivor's mission, taking on leadership roles in ground-level advocacy work and serving as a lead for Cervivor Noir. Her relentless commitment to advocacy has made her a powerful voice in the fight against cervical cancer.

American Cancer Society, Director, ACS NRTCC

Shelly serves as Director of the American Cancer Society National Roundtable on Cervical Cancer. A champion of health equity, Shelly is an outspoken cervical cancer survivor with over 30 years of volunteer and civic engagement history. Her ambitions include advancing systems, policy, and environmental changes to address the social determinates of health and eliminating cervical cancer as a public health problem in her lifetime. A graduate of West Virginia University, Shelly worked nearly a decade at WVU Cancer Institute’s Cancer Prevention and Control, where she was recognized for her HPV vaccination advocacy and for her work engineering and instituting policy, systems, and environmental changes through the WV Breast and Cervical Cancer Screening Program. During this time she also served as a Workgroup leader, Chair and Chair Emeritus of Mountains of Hope, the West Virginia’s Comprehensive Cancer Coalition. Shelly remains involved in the Quality of Life workgroup leading the work to champion legislation to decrease out of pocket costs for oral health services when related to a cancer diagnosis. In her role as Director of the ACS National Roundtable on Cervical Cancer, Shelly works with organizations from across the US to identify and address the problems that no one organization can solve on its own. Utilizing the strength of the ACS Roundtable Model the ACS NRTCC addresses the six greatest challenges identified by stakeholders across the cervical cancer continuum. These priorities were recently featured as poster presentations at the 2023 International Papillomavirus Conference in Washington, DC, and can be viewed at https://cervicalroundtable.org/

American Cancer Society, Program Manager ACS NRTCC

Facilitator